Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

UK researchers investigating Aids immunity

Glenda Cooper
Friday 29 March 1996 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Doctors at a London hospital are monitoring 40 British people in a search for someone who is immune to the Aids virus.

The researchers at Chelsea and Westminster Hospital are studying people who have had repeated exposure to the human immuno-deficiency virus (HIV) but have remained resistant to infection. They hope to report their findings within the year.

Yesterday it was announced that scientists in the US have discovered that Steve Crohn, from New York, has the first known substance in the world that will defeat HIV. Scientists at the Aaron Diamond Aids Research Center in New York, took his white blood cells known as CD4 cells, which are the particular target of HIV, cultured them in the laboratory and tried unsuccessfully to infect them with HIV.

The 40 people being studied in Britain were recruited about a year ago through advertising in HIV clinics and newspapers.

"There were three components we looked for," said Dr Philippa Easterbrook, senior lecturer in infectious diseases and epidemiology. "Firstly that they should have been exposed fairly recently - within the last year. Second, they should have had a very significant level of exposure over a two-year period and third that they should have had an HIV test recently."

Dr Easterbrook said in the past there had been various explanations put forward as to why people did not become infected with HIV, including the fact that they could have been infected by someone who had low-level infection, or a weak form of the virus or that although they were infected it had not shown up in the antibodies.

She said the most recent data made it likely that immune response was an "important explanation", but she added: "We're a long way from picking up information for a specific vaccine but this data clearly has long term application." She called for more studies to be undertaken looking at the offspring of infected mothers who did not go on to develop the virus, partners of haemophiliacs who had been given infected blood, and exposed health care workers.

Professor Frances Gotch, head of immunology at the Chelsea and Westminster, said the US findings were "extremely interesting" and showed "for the first time certain people are non-susceptible to the virus- that gives us hope for a vaccine".

Separate research in Gambia, the result of a collaboration between the Medical Research Council and the Institute of Molecular Medicine in Oxford, showed that some prostitutes had also not succumbed to the virus despite their lifestyles.

"From our research we believed that individual cases who were non-susceptible but had had high exposure were transiently infected," said Professor Gotch. "This gave the body time before CD4 cells were infected which gave other cells the chance to kick in an immune response. This would be the same effect as having a vaccine."

A spokesman for the Terrence Higgins Trust said: "We are cautiously optimistic. Hopefully it will be a small step on the long road to finding a vaccine or effective treatment."

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in